Clinical efficacy and drug resistance of ceftazidime-avibactam in the treatment of Carbapenem-resistant gram-negative bacilli infection

Clinical efficacy and drug resistance of ceftazidime-avibactam in the treatment of Carbapenem-resistant gram-negative bacilli infection

ObjectiveTo examine the clinical efficacy, safety, and resistance of Ceftazidime-Avibactam (CAZ-AVI) in patients with Carbapenem-resistant Gram-negative bacilli (CR-GNB) infections.MethodsWe retrospectively analyzed relevant data of CR-GNB infected patients receiving CAZ-AVI treatment, analyzed rele...

Full description

Bibliographic Details
Main Authors: Shuang Xiao, Qianwen Fu, Youhan Miao, Manna Zhao, Shengwei Lu, Jie Xu, Weifeng Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Microbiology
Subjects:
ceftazidime-avibactam
Polymyxin B
carbapenem-resistant gram-negative bacilli
clinical efficacy
drug resistance
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1198926/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2023.1198926/full

Similar Items